CREDIT SUISSE AG/ - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 87 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
21
-99.8%
0.00%
Q4 2020$91,000
+42.2%
11,604
+16.0%
0.00%
Q3 2016$64,00010,0000.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 524,929$2,588,0006.20%
DAFNA Capital Management LLC 349,592$1,723,0001.07%
Nantahala Capital Management 1,602,903$7,902,0000.39%
Sio Capital Management, LLC 129,583$639,0000.33%
Rock Springs Capital Management LP 524,089$2,584,0000.12%
Orbimed Advisors 1,469,524$7,244,0000.07%
Baker Brothers Advisors 1,137,872$5,609,0000.04%
Lee Financial Co 22,408$110,0000.04%
Spark Investment Management LLC 42,002$207,0000.01%
JENNISON ASSOCIATES LLC 1,385,067$6,565,0000.01%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders